Follicular lymphoma laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Laboratory findings consistent with the diagnosis of follicular lymphoma include histological confirmation, immunophenotyping, immunohistochemistry, molecular genetic analysis and cytogenetics. | Laboratory findings consistent with the diagnosis of follicular lymphoma include histological confirmation, immunophenotyping, immunohistochemistry, molecular genetic analysis and cytogenetics. | ||
==Laboratory Findings== | ==Laboratory Findings== | ||
Laboratory findings consistent with the diagnosis of follicular lymphoma includes<ref>{{cite web | title = Non-Hodgkin's Lymphomas (NCCN.org) | url = http://www.nccn.org/professionals/physician_gls/PDF/nhl.pdf }}</ref> | Laboratory findings consistent with the diagnosis of follicular lymphoma includes<ref>{{cite web | title = Non-Hodgkin's Lymphomas (NCCN.org) | url = http://www.nccn.org/professionals/physician_gls/PDF/nhl.pdf }}</ref> | ||
Revision as of 19:22, 25 August 2015
|
Follicular lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Follicular lymphoma laboratory findings On the Web |
|
American Roentgen Ray Society Images of Follicular lymphoma laboratory findings |
|
Risk calculators and risk factors for Follicular lymphoma laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Laboratory findings consistent with the diagnosis of follicular lymphoma include histological confirmation, immunophenotyping, immunohistochemistry, molecular genetic analysis and cytogenetics.
Laboratory Findings
Laboratory findings consistent with the diagnosis of follicular lymphoma includes[1]
- Histological confirmation by centroblasts and centrocytes
- Immunophenotyping using flow cytometry to detect immunophenotypes like CD20+, CD10+, BCL2+, CD23+/-, CD43-, CD5-, CCND1-, CD10-, BCL2- and BCL6+
- Immunohistochemistry for Ki-67,Aggressive clinical behavior is in association with low-grade follicular lymphoma with a high proliferation index. ( determined by Ki-67 immunostaining)
- Molecular genetic analysis for BCL2 rearrangement
- Cytogenetics or FISH for t(14;18)